- Home
- CETY vs NXTC Comparison
CETY vs NXTC Comparison
Compare CETY & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETY
- NXTC
- Stock Information
- Founded
- CETY 1993
- NXTC 2015
- Country
- CETY United States
- NXTC United States
- Employees
- CETY N/A
- NXTC N/A
- Industry
- CETY Power Generation
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- CETY Utilities
- NXTC Health Care
- Exchange
- CETY Nasdaq
- NXTC Nasdaq
- Market Cap
- CETY 41.0M
- NXTC 40.3M
- IPO Year
- CETY N/A
- NXTC 2019
- Fundamental
- Price
- CETY $0.70
- NXTC $1.37
- Analyst Decision
- CETY
- NXTC Strong Buy
- Analyst Count
- CETY 0
- NXTC 2
- Target Price
- CETY N/A
- NXTC $4.00
- AVG Volume (30 Days)
- CETY 133.5K
- NXTC 43.8K
- Earning Date
- CETY 11-26-2024
- NXTC 11-07-2024
- Dividend Yield
- CETY N/A
- NXTC N/A
- EPS Growth
- CETY N/A
- NXTC N/A
- EPS
- CETY N/A
- NXTC N/A
- Revenue
- CETY $13,548,613.00
- NXTC N/A
- Revenue This Year
- CETY N/A
- NXTC N/A
- Revenue Next Year
- CETY N/A
- NXTC N/A
- P/E Ratio
- CETY N/A
- NXTC N/A
- Revenue Growth
- CETY 296.83
- NXTC N/A
- 52 Week Low
- CETY $0.45
- NXTC $1.03
- 52 Week High
- CETY $2.39
- NXTC $2.57
- Technical
- Relative Strength Index (RSI)
- CETY 41.42
- NXTC 53.73
- Support Level
- CETY $0.61
- NXTC $1.30
- Resistance Level
- CETY $1.27
- NXTC $1.60
- Average True Range (ATR)
- CETY 0.09
- NXTC 0.08
- MACD
- CETY 0.02
- NXTC 0.01
- Stochastic Oscillator
- CETY 18.18
- NXTC 45.91
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business, as well as continuing to support other emerging growth companies with their Clean-tech technologies. It has four segments: Clean Energy HRS & CETY Europe, CETY HK, CETY Renewables and Electronic Manufacturing. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.